Global Pet Diabetes Market is valued USD 15.1084 Billion in 20110 and is projected is to exhibit 8.56% CAGR during the forecast period. The market is projected to be around USD 28.40 Billion by 2026. The growth of the global pet diabetes market can be attributed to rising prevalence of diabetes in pet animals, increase in pet adoption, and growing prevalence of obesity among pet animals.

Diabetes is a medical condition that arises when the body cannot utilize glucose. This condition is caused due to problems with insulin production or function which results in uncontrolled blood sugar levels in pets. Diabetes occurs most commonly in older pets. However, some younger and pregnant pets are also susceptible to diabetes. Dogs and cats are at a higher risk of diabetes. Diabetes arises in female dogs twofold as frequently as male dogs. Some breeds of dogs may be prone to diabetes.
Pet Diabetes Market Dynamics
Data shows that adoption numbers are rising slowly across the US and Europe and have become an additional driver of declining euthanasia numbers in the last decade. Therefore, the cultural shift in society and pet owners relate to dogs that have produced positive shelter trends beyond the decline in intake is projected to drive the global pet diabetes market. The raised levels of control and care dog owners provide to their dogs, as well as the growing perception of dogs as family members, are all indicators of the changing human-dog relationship. The normal process of adoption is time-consuming and cumbersome, sometimes driving away potential adopter which is one of the challenges societies is overcoming in the near future.

At the same time, some side effects related to diabetes medication in pets and lack of awareness and low animal healthcare expenditure in developing regions will limit the growth of the pet diabetes care market.
Pet Diabetes Market Insight
Based on the region, North America holds the largest market share in the market. The U.S. accounted for the highest share in the North America region due to the high pet adoption rate, the presence of major market players. Europe is expected to be the succeeding key market. The major reasons are the increasing trend of companion animals and high investment in R&D by major market players. The Asia Pacific will develop at the highest growth rate due to growing veterinary healthcare expenditure and increasing pet adoption.
Pet Diabetes Market Segmentation
The global Pet Diabetes market is segmented into drug type, device, application, and region. On the basis of the drug type the market is further bifurcated into less than insulin therapy, oral therapy. The market based on device is segmented into glucose monitoring devices, insulin delivery devices. On the basis of the application the market is further bifurcated into less than livestock, companion. Based on the region the market is further segregated into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
Pet Diabetes Market Competitive Landscape
The key players in Pet Diabetes Market are listed as Merck, Zoetis, TaiDoc, Allison Medical, Ulticare, Boehringer Ingelheim Vetmedica Inc., Bayer